Erratum to: Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice (Journal of Leukocyte Biology, (2017), 102, 2, (191-200), 10.1189/jlb.4HI1216-537R);Frontline science: Myeloid cell-specific deletion of cebpb decreases sepsis-induced immunosuppression in mice

Journal of Leukocyte Biology

Volumn 102, Issue 2, 2017, Pages 191-200

  McPeak, Melissa B ^a   Youssef, Dima ^a   Williams, Danielle A ^b   Pritchett, Christopher L ^b   Yao, Zhi Q ^a   McCall, Charles E ^c   El Gazzar, Mohamed ^a  

^a East Tennessee State University   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Immune suppression; Inflammation; MDSC; MicroRNA; Sepsis

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CD11B ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; MICRORNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; CEBPB PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEBPB GENE; CELL DIFFERENTIATION; CELL EXPANSION; CELL LINEAGE; CELL MATURATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FLOW CYTOMETRY; GENE; GENE DELETION; GENE TARGETING; GRANULOCYTE; INNATE IMMUNITY; MALE; MOUSE; MURINE MODEL; MYELOID PROGENITOR CELL; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; STEADY STATE; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNE TOLERANCE; INFLAMMATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID-DERIVED SUPPRESSOR CELLS; REAL-TIME POLYMERASE CHAIN REACTION; SEPSIS;

EID: 85026784040     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1002/jlb.10110     Document Type: Erratum

References (44)

1. Hotchkiss, R. S., Monneret, G., Payen, D. (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862–874.
2. McCall, C. E., El Gazzar, M., Liu, T., Vachharajani, V., Yoza, B. (2011) Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J. Leukoc. Biol. 90, 439–446.
3. McCall, C. E., Yoza, B., Liu, T., El Gazzar, M. (2010) Gene-specific epigenetic regulation in serious infections with systemic inflammation. J. Innate Immun. 2, 395–405.
4. Oberholzer, A., Oberholzer, C., Moldawer, L. L. (2001) Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16, 83–96.
5. Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman II, S. D., Kreisel, D., Krupnick, A. S., Srivastava, A., Swanson, P. E., Green, J. M., Hotchkiss, R. S. (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306, 2594–2605.
6. Hotchkiss, R. S., Karl, I. E. (2003) The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138–150.
7. Ward, P. A. (2011) Immunosuppression in sepsis. JAMA 306, 2618–2619.
8. Remick, D. G. (2007) Pathophysiology of sepsis. Am. J. Pathol. 170, 1435–1444.
9. Shubin, N. J., Monaghan, S. F., Ayala, A. (2011) Anti-inflammatory mechanisms of sepsis. Contrib. Microbiol. 17, 108–124.
10. Otto, G. P., Sossdorf, M., Claus, R. A., Rödel, J., Menge, K., Reinhart, K., Bauer, M., Riedemann, N. C. (2011) The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care 15, R183.
11. Torgersen, C., Moser, P., Luckner, G., Mayr, V., Jochberger, S., Hasibeder, W. R., Dünser, M. W. (2009) Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth. Analg. 108, 1841–1847.
12. Hotchkiss, R. S., Opal, S. (2010) Immunotherapy for sepsis—a new approach against an ancient foe. N. Engl. J. Med. 363, 87–89.
13. Payen, D., Monneret, G., Hotchkiss, R. (2013) Immunotherapy—a potential new way forward in the treatment of sepsis. Crit. Care 17, 118.
14. Brudecki, L., Ferguson, D. A., McCall, C. E., El Gazzar, M. (2012) Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect. Immun. 80, 2026–2034.
15. + population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463–1474.
16. Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., Linke, R. P., Müller, M., Blander, J. M., Tacke, F., Trautwein, C. (2010) Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453–1464.
17. Gabrilovich, D. I., Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162–174.
18. Ostrand-Rosenberg, S., Sinha, P. (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182, 4499–4506.
19. Mathias, B., Delmas, A. L., Ozrazgat-Baslanti, T., Vanzant, E. L., Szpila, B. E., Mohr, A. M., Moore, F. A., Brakenridge, S. C., Brumback, B. A., Moldawer, L. L., Efron, PA; Sepsis, Critical Illness Research Center Investigators. (2016) Human myeloid-derived suppressor cells are associated with chronic immune suppression after severe sepsis/septic shock. Ann. Surg. 265, 827–834.
20. McClure, C., Brudecki, L., Ferguson, D. A., Yao, Z. Q., Moorman, J. P., McCall, C. E., El Gazzar, M. (2014) MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect. Immun. 82, 3816–3825.
21. McClure, C., Ali, E., Youssef, D., Yao, Z. Q., McCall, C. E., El Gazzar, M. (2016) NFI-A disrupts myeloid cell differentiation and maturation in septic mice. J. Leukoc. Biol. 99, 201–211.
22. McClure, C., McPeak, M. B., Youssef, D., Yao, Z. Q., McCall, C. E., El, G. M. (2017) Stat3 and C/EBPβ synergize to induce miR-21 and miR-181b expression during sepsis. Immunol. Cell Biol. 95, 42–55.
23. Hirai, H., Zhang, P., Dayaram, T., Hetherington, C. J., Mizuno, S., Imanishi, J., Akashi, K., Tenen, D. G. (2006) C/EBPβ is required for ‘emergency’ granulopoiesis. Nat. Immunol. 7, 732–739.
24. Sterneck, E., Tessarollo, L., Johnson, P. F. (1997) An essential role for C/EBPβ in female reproduction. Genes Dev. 11, 2153–2162.
25. Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., Förster, I. (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265–277.
26. Brudecki, L., Ferguson, D. A., Yin, D., Lesage, G. D., McCall, C. E., El Gazzar, M. (2012) Hematopoietic stem-progenitor cells restore immunoreactivity and improve survival in late sepsis. Infect. Immun. 80, 602–611.
27. Mazuski, J. E., Sawyer, R. G., Nathens, A. B., DiPiro, J. T., Schein, M., Kudsk, K. A., Yowler, C.; Therapeutic Agents Committee of the Surgical Infections Society. (2002) The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg. Infect. (Larchmt) 3, 161–173.
28. Angele, M. K., Schwacha, M. G., Ayala, A., Chaudry, I. H. (2000) Effect of gender and sex hormones on immune responses following shock. Shock 14, 81–90.
29. De Maio, A., Torres, M. B., Reeves, R. H. (2005) Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock 23, 11–17.
30. Zellweger, R., Wichmann, M. W., Ayala, A., Stein, S., DeMaso, C. M., Chaudry, I. H. (1997) Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit. Care Med. 25, 106–110.
31. Osuchowski, M. F., Welch, K., Siddiqui, J., Remick, D. G. (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177, 1967–1974.
32. Bronte, V., Brandau, S., Chen, S. H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., Rodriguez, P. C., Sica, A., Umansky, V., Vonderheide, R. H., Gabrilovich, D. I. (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150.
33. Janols, H., Bergenfelz, C., Allaoui, R., Larsson, A. M., Rydén, L., Björnsson, S., Janciauskiene, S., Wullt, M., Bredberg, A., Leandersson, K. (2014) A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J. Leukoc. Biol. 96, 685–693.
34. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., Bronte, V. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22, 238–244.
35. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., Calabrese, F., Basso, G., Zanovello, P., Cozzi, E., Mandruzzato, S., Bronte, V. (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor. Immunity 32, 790–802.
36. Ramji, D. P., Foka, P. (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561–575.
37. Zhang, H., Nguyen-Jackson, H., Panopoulos, A. D., Li, H. S., Murray, P. J., Watowich, S. S. (2010) STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 116, 2462–2471.
38. Akagi, T., Saitoh, T., O’Kelly, J., Akira, S., Gombart, A. F., Koeffler, H. P. (2008) Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPβ-deficient hematopoietic cells. Blood 111, 2999–3004.
39. Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M. L., Nervi, C., Bozzoni, I. (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 123, 819–831.
40. Laslo, P., Pongubala, J. M., Lancki, D. W., Singh, H. (2008) Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system. Semin. Immunol. 20, 228–235.
41. Condamine, T., Gabrilovich, D. I. (2011) Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32, 19–25.
42. Martin, G. S., Mannino, D. M., Eaton, S., Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546–1554.
43. Martin, G. S., Mannino, D. M., Moss, M. (2006) The effect of age on the development and outcome of adult sepsis. Crit. Care Med. 34, 15–21.
44. Unsinger, J., McGlynn, M., Kasten, K. R., Hoekzema, A. S., Watanabe, E., Muenzer, J. T., McDonough, J. S., Tschoep, J., Ferguson, T. A., McDunn, J. E., Morre, M., Hildeman, D. A., Caldwell, C. C., Hotchkiss, R. S. (2010) IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol. 184, 3768–3779.